⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5828823 | 0.66 | — | — | |
| SCHEMBL128416 | 0.65 | — | — | |
| SCHEMBL23702307 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL5791474 | 0.61 | METAP2 (0.34) | — | |
| SCHEMBL156284 | 0.59 | — | — | |
| SCHEMBL3934057 | 0.59 | — | — | |
| SCHEMBL3938609 | 0.56 | — | — | |
| SCHEMBL901559 | 0.56 | — | — | |
| SCHEMBL23702165 | 0.56 | — | — | |
| SCHEMBL9995236 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057346-A | USED TO DELAY OR SUPPRESS THE TRANSITION OF A RETROVIRAL INFECTION FROM A LATENT TO A VIRULENT CONDITION, THEREBY AMELIORATING RETROVIRALLY CAUSED DISEASES SUCH AS AIDS, ARE ALSO USEFUL IN CANCER TREATMENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-02 | — | — | US | claimed |
| US-5880129-A | ADMINISTERING ANTIPROLIFERATIVE, ANTIINVASIVE, ANTIMETASTASIS AMOUNT OF SELECTED SIGNAL TRANSDUCTION INHIBITOR | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-03-09 | — | — | US | claimed |
| US-5602156-A | ADMINISTERING IN TREATMENT FOR NERVE DISORDERS, ARTHRITIS, ALZHEIMER'S DISEASE, WOUND HEALING, CORNEAL ULCERS AND FERTILITY PROBLEMS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-02-11 | — | — | US | claimed |
| US-5405782-A | Reverse phase liquid chromatography | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-04-11 | — | — | US | claimed |
| EP-0644880-A1 | 1,2,3-TRIAZOLE AND IMIDAZOLE COMPOUNDS AND THEIR ANTITUMOR USE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1995007695-A1 | METHOD FOR INHIBITING METALLOPROTEINASE EXPRESSION | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1994023293-A1 | A DETECTION AND QUANTITATION METHOD FOR THERAPEUTIC AGENTS IN BLOOD | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-13 | — | — | WO | claimed |
| WO-1993025536-A1 | 1,2,3-TRIAZOLE AND IMIDAZOLE COMPOUNDS AND THEIR ANTITUMOR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-12-23 | — | — | WO | claimed |
| WO-2023076772-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| EP-4174491-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-03 | — | — | EP | disclosed |
| US-11512342-B1 | Compositions and methods for detecting pyrophosphate products of enzyme reactions using pyridylazoaniline dyes | NEW ENGLAND BIOLABS, INC. (US) | 2022-11-29 | — | — | US | disclosed |
| US-20210188758-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | VTVX HOLDINGS II LLC | 2021-06-24 | — | — | US | disclosed |
| US-10947180-B2 | Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists | VTV THERAPEUTICS LLC (US) | 2021-03-16 | — | — | US | disclosed |
| US-20200215073-A1 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | HIGH POINT PHARMACEUTICALS, LLC | 2020-07-09 | — | — | US | disclosed |
| WO-1995008327-A1 | METHOD FOR INHIBITING ANGIOGENESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-30 | — | — | WO | disclosed |
| EP-0644880-A1 | 1,2,3-TRIAZOLE AND IMIDAZOLE COMPOUNDS AND THEIR ANTITUMOR USE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-29 | — | — | EP | disclosed |
| WO-1995007695-A1 | METHOD FOR INHIBITING METALLOPROTEINASE EXPRESSION | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-23 | — | — | WO | disclosed |
| US-5359078-A | Interrupts the signalling pathways required for proliferation and metastasis of cancer cells | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-25 | — | — | US | disclosed |
| WO-1994023293-A1 | A DETECTION AND QUANTITATION METHOD FOR THERAPEUTIC AGENTS IN BLOOD | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1993025536-A1 | 1,2,3-TRIAZOLE AND IMIDAZOLE COMPOUNDS AND THEIR ANTITUMOR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-12-23 | — | — | WO | disclosed |